← Back to patent-cliff list
Arsenious Acid
Tier C — Watch / tradeArsenious Acid
-
Originator
1999
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Indications (approved)：Multiple myeloma, Lung cancer, Liver cancer, Cervical cancer, Acute promyelocytic leukaemia, Colon cancer, Lymphoma, Breast cancer
Regional status
US
-
EU
-
China
Approved
1999-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Arsenious Acid?
Approved indications include: Multiple myeloma, Lung cancer, Liver cancer, Cervical cancer, Acute promyelocytic leukaemia, Colon cancer, Lymphoma, Breast cancer.
When does the Arsenious Acid patent expire?
No public expiry year is available for Arsenious Acid yet; this page updates once verified.
How do I get a quote for Arsenious Acid intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27